Electrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Sudden death can occur as a consequence of cardiac-conduction abnormalities in the neuromuscular disease myotonic dystrophy type 1. The determinants of the risk of sudden death remain imprecise. METHODS: We assessed whether the electrocardiogram (ECG) was useful in predicting sudden death in 406 adult patients with genetically confirmed myotonic dystrophy type 1. A patient was characterized as having a severe abnormality if the ECG had at least one of the following features: rhythm other than sinus, PR interval of 240 msec or more, QRS duration of 120 msec or more, or second-degree or third-degree atrioventricular block. RESULTS: Patients with severe abnormalities according to the entry ECG were older than patients without severe abnormalities, had more severe skeletal-muscle impairment, and were more likely to have heart failure, left ventricular systolic dysfunction, or atrial tachyarrhythmia. Such patients were more likely to receive a pacemaker or an implantable cardioverter-defibrillator during the follow-up period. During a mean follow-up period of 5.7 years, 81 patients died; there were 27 sudden deaths, 32 deaths from progressive neuromuscular respiratory failure, 5 nonsudden deaths from cardiac causes, and 17 deaths from other causes. Among the 17 patients who died suddenly in whom postcollapse rhythm was evaluated, a ventricular tachyarrhythmia was observed in 9. A severe ECG abnormality (relative risk, 3.30; 95% confidence interval [CI], 1.24 to 8.78) and a clinical diagnosis of atrial tachyarrhythmia (relative risk, 5.18; 95% CI, 2.28 to 11.77) were independent risk factors for sudden death. CONCLUSIONS: Patients with adult myotonic dystrophy type 1 are at high risk for arrhythmias and sudden death. A severe abnormality on the ECG and a diagnosis of an atrial tachyarrhythmia predict sudden death. (ClinicalTrials.gov number, NCT00622453.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210629 · Cited by 3,300
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A. J., Church, D., Aburatani, H., Hunter, K., Stanton, V. P., Thirion, J.-P., Hudson, T., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,777
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
An Unstable Triplet Repeat in a Gene Related to Myotonic Muscular Dystrophy
Fu, Y. H., Pizzuti, A., Fenwick, R. G., King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P., et al. (1992) · Science · doi:10.1126/science.1546326 · Cited by 1,455
Gregoratos, G., Abrams, J., Epstein, A. E., Freedman, R. A., Hayes, D. L., Hlatky, M. A., Kerber, R. E., Naccarelli, G. V., Schoenfeld, M. H., Silka, M. J., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02528-7 · Cited by 1,266
Committee Members, Gregoratos, G., Abrams, J., Epstein, A. E., Freedman, R. A., Hayes, D. L., Hlatky, M. A., Kerber, R. E., Naccarelli, G. V., Schoenfeld, M. H., et al. (2002) · Circulation · doi:10.1161/01.cir.0000035996.46455.09 · Cited by 910
Chugh, S. S., Jui, J., Gunson, K., Stecker, E. C., John, B. T., Thompson, B., Ilias, N., Vickers, C., Dogra, V., Daya, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.029 · Cited by 795
Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy
Buxton, J., Shelbourne, P., Davies, J., Jones, C., Tongeren, T. V., Aslanidis, C., de Jong, P., Jansen, G., Anvret, M., Riley, B., et al. (1992) · Nature · doi:10.1038/355547a0 · Cited by 620
Cloning of the essential myotonic dystrophy region and mapping of the putative defect
Aslanidis, C., Jansen, G., Amemiya, C., Shutler, G., Mahadevan, M., Tsilfidis, C., Chen, C., Alleman, J., Wormskamp, N. G. M., Vooijs, M., et al. (1992) · Nature · doi:10.1038/355548a0 · Cited by 498
A 10-year study of mortality in a cohort of patients with myotonic dystrophy
Mathieu, J., Allard, P., Potvin, L., Prévost, C., & Bégin, P. (1999) · Neurology · doi:10.1212/wnl.52.8.1658 · Cited by 414
Research works printed but not linked: 2
- Florek RC, 1990, West J Med, 153, 24
- 10.1001/jama.271.11.840 · DOI · Paper page
Cited by
Items 401–500 of 511
Ambroggi, G. D., Ali, H., Cappato, R., Sansone, V., & AMBROGGI, L. D. (2019) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000863 · Cited by 1
A dystrophia myotonica 1-es típusának sokszervi megjelenése
Varga, D., & Pál, E. (2019) · Orvosi Hetilap · doi:10.1556/650.2019.31505 · Cited by 1
“5,7 éves követés után a leggyakoribb EKG-abnormalitásoknak a pitvari tachyarrhythmiák mutatkoztak [18].”
Diagnostic Criteria of Left Ventricular Dysfunction in Patients With Myotonic Dystrophy Type 1
Toro, A. D., Giuliani, L., Serio, A., & Arbustini, E. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.09.016 · Cited by 1
Fast Progressing His-Purkinje Conduction Disturbances in a Myotonic Dystrophy Pacient.
Ciudin, R. N., Dragotoiu, N., Sipos, S., Tesloianu, D. N., Ursaru, A. M., Brezeanu, R. C., & Coman, I. M. (2018) · Europe PMC (PubMed Central) · doi:10.26574/maedica.2018.13.2.152 · Cited by 1
Ahmad, S., & Kabunga, P. (2021) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytab409 · Cited by 1
“In addition, progressive cardiac conduction disease and/or ventricular arrhythmias affect the majority of patients with MD1 and are major causes of sudden cardiac death (SCD).(2) Permanent pacemaker (PPM) implantation is recommended in MD1 patients who have evidence of second-degree, third-degree”
BackgroundInfluentialIndications for Permanent and Temporary Cardiac Pacing
John, R. M. (2014) · Wiley eBooks · doi:10.1002/9781118459553.ch1 · Cited by 1
Groh, W. J. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.06.031 · Cited by 1
Self-citationSimmons, Z. (2012) · Journal of Clinical Neuromuscular Disease · doi:10.1097/cnd.0b013e31824db0fe · Cited by 1
Self-citationJoosten, I. B. T., Okkersen, K., van Engelen, B. G. M., & Faber, C. G. (2020) · doi:10.1002/9781119432692.ch39 · Cited by 1
Cardiac Involvement of Myotonic Dystrophy
Itoh, H. (2022) · リハビリテーション医学 : 日本リハビリテーション医学会誌 · doi:10.2490/jjrmc.59.161 · Cited by 1
RBFOX2 Autoregulation Promotes Cardiomyocyte Transcriptome Maturation and Differentiation
Huang, M., Ladha, F. A., Wang, Y., Trembley, M. A., Yin, H., Zheng, R., Prondzynski, M., Tharani, Y., Akerberg, A. A., Aigner, S., et al. (2026) · Circulation Research · doi:10.1101/2025.10.28.685214 · Cited by 3
The Role of Clinical Observation: Red Flag 1 — Cardiomyopathies and Skeletal Muscle Involvement
Sinagra, G., Camerini, F., & Fabris, E. (2012) · Springer eBooks · doi:10.1007/978-88-470-2757-2_3
Cardiovascular magnetic resonance : a key to imaging cardiac function
Schalla, S. M. (2015) · Research Publications (Maastricht University) · doi:10.26481/dis.20150706ss
Sudden Natural Deaths in Infancy and Childhood
Langlois, N. E. I., & Byard, R. W. (2011) · Forensic pathology reviews · doi:10.1007/978-1-61779-249-6_1
Miocardiopatía secundaria a distrofia de Steinert
Jorge, B. A. L., Lanzieri, P. G., do Carmo, F. B., Haffner, P., Jorge, A. J. L., & Martins, W. D. A. (2012) · Insuficiencia cardiaca: revista especializada en insuficiencia cardíaca, cardiometabolismo e hipertensión pulmonar
Distrofia miotónica congénita de Steinert. Presentación de una paciente
Agüero, R. Y. M., & Pacheco, L. M. C. (2012) · Acta Médica del Centro
CASO 4-2015: FEMENINA DE 42 AÑOS CON ICTUS Y DISTROFIA MIOTONICA TIPO 1
Murillo, P. C. (2015) · Revista Clínica Escuela de Medicina UCR-HSJD · doi:10.15517/rc_ucr-hsjd.v5i2.18867
Wahbi, K., Meune, C., Porcher, R., Bécane, H. M., Lazarus, A., Laforêt, P., Stojkovic, T., Béhin, A., Radvanyi, H., Eymard, B., et al. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.06.302
Distrofias musculares, miopatías metabólicas y tóxicas
Cabrera‐Serrano, M. (2015) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2015.03.004
CARDIAC ARRHYTHMIAS BLAMED FOR MOST SUDDEN DEATHS IN MYOTONIC DYSTROPHY PATIENTS
Samson, K. (2008) · Neurology Today · doi:10.1097/01.nt.0000335573.41374.e6
Fayssoil, A., & Nardi, O. (2011) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2010.12.009
Pathologie cardiaque aiguë chez un patient porteur d’une myopathie
Nardi, O., Fayssoil, A., & Orlikowski, D. (2008) · Journal Européen des Urgences · doi:10.1016/j.jeur.2008.10.005
Myotone Dystrophie Typ 1 (DM1/Curschmann-Steinert-Erkrankung)
Schara, U., & Schneider‐Gold, C. (2014) · Springer eBooks · doi:10.1007/978-3-662-44239-5_20
Compound heterozygous myotonic dystrophy type 1
Finsterer, J., & Zarrouk‐Mahjoub, S. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36798
“Patients with DM1 not only develop cardiac conduction defects (most frequently type I atrioventricular (AV) blocks [Groh et al., 2008]), but also cardiomyopathy [Park et al., 2009], particularly dilated cardiomyopathy [Kilic et al., 2007], and left ventricular hypertrabeculation (noncompaction)…”
BackgroundRare Cause of Wide QRS Tachycardia
Mironov, N. Y., Миронова, Н. А., Абдулатиповна, С. М., Стукалова, О. В., & Sp, G. (2015) · Case Reports in Cardiology · doi:10.1155/2015/151269
Sudden Cardiac Death in Dilated Cardiomyopathy and Skeletal Muscular Dystrophy
van Rijsingen, I. A. W., van der Kooi, A. J., & Pinto, Y. M. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4978-1_3
Steinert Myotonic Dystrophy: A Family Case Report and Literature Review
Flores-López, E. E. N., Tovilla-Ruiz, I. C. K., García-Padilla, L. E., Sandoval-Gutiérrez, E. R. B., & Álvarez-Torrecilla, L. L. C. (2014) · Medicina Interna de México
高寛, 湯., 正広, 柏., 和也, 立., 睦房, 渡., & 祐一, 濱. (2015) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.1002/jja2.12040
0457: Atrial flutter in myotonic dystrophy type 1: patient characteristics and clinical outcome
Wahbi, K., Sebag, F. A., Lellouche, N., Lazarus, A., Bécane, H. M., Bassez, G., Stojkovic, T., Fayssoil, A., Laforêt, P., Béhin, A., et al. (2016) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(16)30077-5
“Cardiac involvement is frequent in DM1 and may include conduction system disease, dilated cardiomyopathy, ventricular and supraventricular arrhythmias [3–7].”
BackgrounddeLorimier, E. (2015) · Scholars' Bank (University of Oregon)
Rayan, D. L. R., & Turner, C. (2016) · doi:10.1093/med/9780199664771.003.0009
Orthopedic Surgery in Neuromuscular Disorders
Warner, W. C. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0372-6.00009-8
Abnormalities in Electrocardiogram Secondary to Systemic Pathology
Miranda, C., Muller, B., Taqatqa, A., Hu, J. J., & Abdulla, R. (2016) · Springer eBooks · doi:10.1007/978-3-319-26258-1_9
Oberbauchschmerzen, Übelkeit und Brechreiz bei einer 63-jährigen Patientin
Schwarzer, S., & Rapis, K. (2017) · Der Internist · doi:10.1007/s00108-017-0271-7
Kim, H. J., 박윤길, & Kim, D. H. (2014) · Jouranl of Korean Association of EMG Electrodiagnostic Medicine · doi:10.18214/jkaem.2014.16.2.64
“Groh 등이 발표한 것과 같이 12-전극 심전도 검사 상 동리듬 외의 리듬을 보이거나 PR 간격이 240 msec 이상이거나 QR 지속시간이 120 msec 이상이거나 2도 방실차단이나 3도 방실차단이 관찰된 경우 부정맥이 있 다고 간주하였다.(11) 호흡기계 합병증은 인공호흡기를 사 용할 경우 호흡기계 합병증이 있다고 간주하였다.”
InfluentialKardiomyopathien bei Muskeldystrophien
Błaszczyk, E., Perrot, A., Schmacht, L. M., Lim, C., Spuler, S., & Schulz‐Menger, J. (2017) · Aktuelle Kardiologie · doi:10.1055/s-0043-122685
“entwickeln 17–48% der Patienten brady- oder tachykarde Herzrhythmusstörungen [17,18].”
BackgroundCardiovascular Manifestations of Myotonic Dystrophy
Vivekananda, U., Hanna, M. G., & Turner, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-66114-8_18
Taquicardia ventricular como expresión de Distrofia Miotónica tipo 1
Navarrete, W., Armijo, G., Aguayo, R., & Cisternas, C. (2017) · Revista chilena de cardiología · doi:10.4067/s0718-85602017000300239
Arrhythmia in Neurological Disease
Zghaib, T., & Nazarian, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00100-0
Sinus Node Disease and Cardiac Conduction Disease
Schweizer, P. A. (2018) · Cardiac and vascular biology · doi:10.1007/978-3-319-77812-9_9
Clinical Dystrophia Myotonica first presenting as Gestational Diabetes
Eteiwi, S. (2017) · Endocrinology and Diabetes Open Access · doi:10.31021/edoa.20181101
“Cardiac involvement is the main reason of the mortality among DM patients, and sudden death may occur in patients with severe forms of conduction defects [14].”
Background2018 KHRS Guidelines for Catheter Ablation of Ventricular Arrhythmias – Part2
Kim, J.-Y., Kim, S., Kim, Y. R., Kim, Y.-N., Kim, J., Kim, T., Nam, G., Roh, S., Park, K., Park, H., et al. (2018) · International Journal of Arrhythmia · doi:10.18501/arrhythmia.2018.007
Consider cardiac and non-cardiac predictors of sudden death in myotonic dystrophy type 1
Finsterer, J., & Stöllberger, C. (2019) · doi:10.36811/jcshd.2019.110005
Matsunaga, K., Miyake, Y., Noma, T., & Minamino, T. (2019) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2019.10.017
“VT in patients with myotonic dystrophy.(3) However, myotonic dystrophy is often underdiagnosed, because the muscle atrophy is compensated by slow disease progression.”
BackgroundAlbakri, A. (2019) · Clinical and Medical Investigations · doi:10.15761/cmi.1000189
“Conduction disturbances prevalent in DM patients affecting between 30% and 75% of DM1 patients [85].”
BackgroundA Young Patient Presenting with Atrioventricular Block Diagnosed as Myotonic Dystrophy
Onoda, H., Imamura, T., Ushijima, R., Sobajima, M., & Kinugawa, K. (2020) · Internal Medicine · doi:10.2169/internalmedicine.4259-19
Two Sides of the Same Coin in Myotonic Dystrophy Type 1
Arias, M. A., Pachón, M., & Loughlin, G. (2020) · Circulation · doi:10.1161/circulationaha.119.045563
Roye, D. P., Sheha, E. D., & Xu, N. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417044-5.00052-4
Turner, C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00139-7
Indications for permanent cardiac pacing
John, R. M. (2020) · Wiley eBooks · doi:10.1002/9781119578376.ch1
Sirico, G., Montisci, A., Secchi, F., & Mantica, M. (2020) · PubMed Central · doi:10.36185/2532-1900-006
Ventricular Tachycardia in a Patient with Neuromuscular Disease
Tomaselli, G. F., & Barth, A. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-28533-3_49
16 Years History of Presyncope: An Unexpected Presentation of Myotonic Dystrophy
Gürses, A. A., Güney, F., Genç, B. O., & Yürüten, B. (2020) · Selçuk Tıp Dergisi · doi:10.30733/std.2020.01366
Hereditary Neuromuscular Diseases and Cardiac Involvement
van der Kooi, A. J., & de Visser, M. (2010) · Springer eBooks · doi:10.1007/978-1-84996-471-5_24
Assessing Prevalence and Characteristics of Rare Disease Cardiomyopathies: A Modest Proposal
Plehn, J. F. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.09.012
Cardiac Complications Associated with Neuromuscular Diseases
Govindarajan, R., & Idiculla, P. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-53145-4_4 · Cited by 1
Diagnostyka kardiologiczna u chorych z chorobami nerwowo-mięśniowymi
Marchel, M., Ostrowska, E., Wysińska, J., & Tymińska, A. (2020) · Folia Cardiologica · doi:10.5603/fc.2020.0035
Altered drug metabolism and increased susceptibility to fatty liver disease in myotonic dystrophyPreprint
Dewald, Z., Gupta, A. S., Chembazhi, U. V., & Kalsotra, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.06.438688
“In the case of a few anesthetics, the patient may require intervention to prevent death 18,37 .”
BackgroundGetting a grip on myotonic dystrophy type 1
Hermans, M. C. E. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20130621mh · Cited by 1
II度以上の房室ブロックを伴う筋緊張性ジストロフィに対する予防的植込み型除細動器(ICD)植え込みの必要性
Morita, H., 伸洋, 西., 聡, 永., 一文, 中., 河野, 晋., 研吾, 草., & 伊藤, 浩. (2011) · 心臓 · doi:10.11281/shinzo.43.s2_39
Weiss, N., & Eymard, B. (2012) · Réanimation · doi:10.1007/s13546-012-0515-4
“Les complications conduisant le patient en réanimation sont de plusieurs ordres : insuffisance respiratoire résultant d’une atteinte des muscles respiratoires, auxquels s’ajoutent souvent un dysfonctionnement de la commande centrale, dont la somnolence est une autre manifestation, des troubles sévères de déglutition a…”
BackgroundFlabeau, O., & Bisson, T. (2021) · médecine/sciences · doi:10.1051/medsci/2021190
“L’importance du suivi cardiologique pourrait être expliqué par l’implication thérapeutique engendrée par le dépistage des troubles conductifs et rythmiques, puisqu’un tiers des décès sont d’origine cardio-vasculaire [7, 8] dans cette pathologie, mais aussi par la démographie médicale dense localement permettant un acc…”
BackgroundOrthopedic Surgery in Neuromuscular Disorders
Warner, W. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-71317-7.00009-3
Cardiac Magnetic Resonance Findings and Prognosis in Type 1 Myotonic DystrophyPreprint
Leali, M., Aimo, A., Ricci, G., Torri, F., Todiere, G., Vergaro, G., Grigoratos, C., Giannoni, A., Aquaro, G. D., Siciliano, G., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1217399/v1
(2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283313b14
Neuromuscular Cardiomyopathies
Kamdar, F. D., Mammen, P. P. A., & Garry, D. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-44577-9_12
Cardiac Magnetic Resonance Findings and Prognosis in Type 1 Myotonic DystrophyPreprint
Leali, M., Aimo, A., Ricci, G., Torri, F., Todiere, G., Vergaro, G., Grigoratos, C., Giannoni, A., Aquaro, G. D., Siciliano, G., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4057205
Simmons, Z. (2008) · Journal of Clinical Neuromuscular Disease · doi:10.1097/cnd.0b013e31818d4eb6
Self-citationSmits, B. W., & Rodríguez, J. (2018) · doi:10.1002/9781118777251.ch16
Hereditary Neuromuscular Diseases and Cardiac Involvement
van Westrum, S. M. S., Wahbi, K., Bonne, G., & van der Kooi, A. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-45457-9_22
Moxley, R. T., & Heatwole, C. R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0435-8.00089-5
Hereditary Cardiac Conduction Diseases
Tadros, R., & Cadrin‐Tourigny, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-45457-9_17
Notfälle bei Patienten mit neuromuskulären Erkrankungen
Wenninger, S. (2022) · Notfallmedizin up2date · doi:10.1055/a-1500-4451
Bouzková, K., Kubánek, M., Krebsová, A., Piherová, L., Ridzoň, P., Roubíček, T., Kmoch, S., Melenovský, V., & Kautzner, J. (2022) · Cor et Vasa · doi:10.33678/cor.2021.119
Prevention of Adverse Outcomes and Treatment Side Effects in Patients with Neuromuscular Disorders
Grover, K. M., & Sripathi, N. (2022) · Seminars in Neurology · doi:10.1055/s-0042-1758779
Myotonic Dystrophy Type 2 and Cardiomyopathy
Rohani, A. (2023) · Clinical cases in cardiology · doi:10.1007/978-3-031-24528-2_26
A rare case of myotonic dystrophy type 1 presenting with Torsades de pointes
Handa, A., & Kakkar, R. (2023) · IHJ Cardiovascular Case Reports (CVCR) · doi:10.1016/j.ihjccr.2023.03.002
Dystrophic Myotonia: A Literature Review
Рушкевич, Ю. Н., Мальгина, Е. В., Гусина, А. А., Лихачев, С. А., Khodulev, V. I., Григорович, Т. В., Корбут, Т. В., & Брант, Е. В. (2023) · Неврология и нейрохирургия Восточная Европа · doi:10.34883/pi.2023.13.2.044
Myotonic dystrophy type 1: clinical genetics and multisystem involvement
Joosten, I. B. T. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231023ij
Maleszewski, J. J., Burke, A. P., Veinot, J. P., & Edwards, W. D. (2023) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477299-ch19
Kara, S. C., Doğan, M., & Canpolat, U. (2024) · European Journal of Therapeutics · doi:10.58600/eurjther2038
Schneider‐Gold, C., & Weber, F. (2024) · DGNeurologie · doi:10.1007/s42451-024-00646-3
Systemic Diseases and Heart Block
Sabzwari, S. R. A., & Tzou, W. S. (2024) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2024.03.008
Cardiac manifestations in myotonic dystrophy type 1
Г., К. А., Erokhina, E. K., Витальевна, Ш. К., Melnik, E. A., Khrobostova, A. N., Filipenko, M. B., Arakelyants, A. A., Peters, T., & Павликова, Е. П. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2024-3999
Cardiac Involvement With or Without Myopathy
Wahbi, K., & Hachmi, M. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00321-3
Electrical Alternance in a Patient With Type 1 Myotonic Dystrophy: What Diagnosis?
Vitale, G., Ortolani, P., & Pizzi, C. (2025) · Circulation · doi:10.1161/circulationaha.125.074568
Sudden Death Caused by Bilateral Diaphragmatic Eventration in Myotonic Dystrophy Type 1
Wu, S., & Prahlow, J. A. (2025) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0000000000001073
Jewett, G., Luk, C., Osman, H., & Pfeffer, G. (2025) · Journal of Neuromuscular Diseases · doi:10.1177/22143602251389759
“Practice guidelines are largely based on identifying speci fi c ECG abnormalities that predict increased risk of sudden cardiac death, 60 but people with DM1 are at risk of severe cardiac conduction disease even when ECG is normal.”
Lorca, R., Alén, A., Abós, C. M., de Frutos, F., Báez‐Ferrer, N., Peña‐Peña, M. L., Villacorta, E., Ripoll‐Vera, T., Zorio, E., Martínez, A., et al. (2025) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101851
“The unstable CTG repeat expansion tends to further increase over an individual ’ s lifetime and in successive generations, accounting for the genetic anticipation phenomenon, defined as earlier onset and greater symptom severity in subsequent generations [5,6].”
Calcagnino, M. M., & McKenna, W. J. (2010) · Springer eBooks · doi:10.1007/978-1-84996-153-0_2
Pan, Y., Jiang, Y., Wan, J., 胡正茂, Jiang, H., Shen, L., Tang, B., Tian, Y., & Liu, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26613679
Pan, Y., Jiang, Y., Wan, J., 胡正茂, Jiang, H., Shen, L., Tang, B., Tian, Y., & Liu, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26613682
Multisystem Features in Adult-Onset Myotonic Dystrophy Type 1: An Integrative Case Analysis
Böckels, L., Alexa, D., Cretu, R. A., Vicol, M., Hodorogea, B., Gramada, D., Apostol, G., Achiroaie, D., Bîlcu, R. V., & Cuciureanu, D. I. (2025) · Balneo and PRM Research Journal · doi:10.12680/balneo.2025.928
Cardiac conduction abnormalities in myotonic dystrophy type I: The ongoing value of the ECG
Abumayyaleh, M., Schupp, T., Behnes, M., & Akın, İ. (2026) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101860
“Indeed, ECG changes such as PR-interval prolongation have been previously described in myotonic dystrophy type 1 [6].”
Fernandes, A. S. N., Dias, M. P. S., Conde, I. M., Vilela, F. S., Ferreira, C. O., Marques, J. M. G. S., & Costa, S. A. A. R. D. R. (2026) · REC CardioClinics · doi:10.1016/j.rccl.2025.12.007
Taşkırdı, E. D., Ünalp, A., Yılmaz, Ü., Meşe, T., & Yılmazer, M. M. (2026) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2026.154198 · Cited by 1
Diseases of the Nervous System
Brenner, D. (2026) · Springer eBooks · doi:10.1007/978-3-031-90919-1_34-1
Fading Muscle and a Flaccid Bladder: Atonic Bladder in a Case of Myotonic Dystrophy—A Case Report
Ravichandran, P. Y., Kalpana, R., & Madhavan, K. S. (2026) · Annals of Neurosciences · doi:10.1177/09727531251409516
diniz, D. D. D. (2018) · theses.fr (ABES) · doi:10.70675/d6c5ca9bz4308z4438z8e42zb8ffb6b57e7a
Metadata
- Authors
- Groh, W. J., Groh, M. R., Saha, C., Kincaid, J. C., Simmons, Z., Ciafaloni, E., Pourmand, R., Otten, R. F., Bhakta, D., Nair, G. V., Marashdeh, M. M., Zipes, D. P., & Pascuzzi, R. M.
- Affiliations
- Indiana University Indianapolis (US)
- Pennsylvania State University (US)
- University of Rochester Medicine (US)
- State University of New York (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-06-19
- Volume
- 358
- Issue
- 25
- Pages
- 2688-2697
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2083028245
- Cited by
- 511
- References
- 32
- Citations by year
- 2026: 19 · 2025: 21 · 2024: 19 · 2023: 22 · 2022: 26 · 2021: 30 · 2020: 34 · 2019: 31 · 2018: 36 · 2017: 39 · 2016: 34 · 2015: 28 · 2014: 32 · 2013: 20 · 2012: 32
- FWCI
- 20.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Center for Research Resources (MO1 RR00750-27S1, M01RR000750)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- myotonic dystrophy type 1, sudden death, electrocardiographic abnormalities, atrial tachyarrhythmia, ventricular tachyarrhythmia, cardiac conduction disorders, atrioventricular block, risk factors, implantable cardioverter-defibrillator, cardiac pacemaker, neuromuscular disorders
- MeSH terms
- Adult, Arrhythmias, Cardiac, Cause of Death, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myotonic Dystrophy, Prognosis, Risk Factors, Tachycardia, Death, Sudden, Cardiac
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.